Artificial signal transduction therapy: a futuristic approach to disease treatment.
The Weizmann Institute of Science, Herzl St 234, Rehovot 7610001, Israel.
Ronny
R
Peri-Naor
The Weizmann Institute of Science, Herzl St 234, Rehovot 7610001, Israel.
Leila
L
Motiei
The Weizmann Institute of Science, Herzl St 234, Rehovot 7610001, Israel.
David
D
Margulies
D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D020794:Receptor Protein-Tyrosine Kinases
artificial cell signaling pathways; drug development; protein–protein interactions; signal transduction therapy